422 related articles for article (PubMed ID: 33307138)
61. Extending and validating the Baveno VI criteria for the exclusion of high-risk varices.
Barbulescu A; Ratiu I; Sporea I; Lungeanu D; Lupusoru R; Miutescu B; Danila M; Popescu A; Sirli R
Med Ultrason; 2021 Aug; 23(3):265-270. PubMed ID: 33657192
[TBL] [Abstract][Full Text] [Related]
62. Accuracy of non-invasive methods/models for predicting esophageal varices in patients with compensated advanced chronic liver disease secondary to nonalcoholic fatty liver disease.
Galizzi HO; Couto CA; Taranto DOL; Araújo SIO; Vilela EG
Ann Hepatol; 2021; 20():100229. PubMed ID: 32745630
[TBL] [Abstract][Full Text] [Related]
63. Long-term changes of liver stiffness values assessed using transient elastography in patients with chronic hepatitis B receiving entecavir.
Kim MN; Kim SU; Kim BK; Park JY; Kim DY; Ahn SH; Han KH
Liver Int; 2014 Sep; 34(8):1216-23. PubMed ID: 24267737
[TBL] [Abstract][Full Text] [Related]
64. Acoustic radiation force impulse elastography as compared to transient elastography and liver biopsy in patients with chronic hepatopathies.
Sporea I; Sirli RL; Deleanu A; Popescu A; Focsa M; Danila M; Tudora A
Ultraschall Med; 2011 Jan; 32 Suppl 1():S46-52. PubMed ID: 20603783
[TBL] [Abstract][Full Text] [Related]
65. Transient and 2-Dimensional Shear-Wave Elastography Provide Comparable Assessment of Alcoholic Liver Fibrosis and Cirrhosis.
Thiele M; Detlefsen S; Sevelsted Møller L; Madsen BS; Fuglsang Hansen J; Fialla AD; Trebicka J; Krag A
Gastroenterology; 2016 Jan; 150(1):123-33. PubMed ID: 26435270
[TBL] [Abstract][Full Text] [Related]
66. Prediction of High-Risk Varices in Patients with Compensated Advanced Chronic Liver Disease in Saudi Arabia.
Ismail M
Clin Exp Gastroenterol; 2023; 16():117-127. PubMed ID: 37489180
[TBL] [Abstract][Full Text] [Related]
67. Impact of controlled attenuation parameter on detecting fibrosis using liver stiffness measurement.
Karlas T; Petroff D; Sasso M; Fan JG; Mi YQ; de Lédinghen V; Kumar M; Lupsor-Platon M; Han KH; Cardoso AC; Ferraioli G; Chan WK; Wong VW; Myers RP; Chayama K; Friedrich-Rust M; Beaugrand M; Shen F; Hiriart JB; Sarin SK; Badea R; Lee HW; Marcellin P; Filice C; Mahadeva S; Wong GL; Crotty P; Masaki K; Bojunga J; Bedossa P; Keim V; Wiegand J
Aliment Pharmacol Ther; 2018 Apr; 47(7):989-1000. PubMed ID: 29446106
[TBL] [Abstract][Full Text] [Related]
68. Noninvasive screening for liver fibrosis and portal hypertension by transient elastography--a large single center experience.
Reiberger T; Ferlitsch A; Payer BA; Pinter M; Schwabl P; Stift J; Trauner M; Peck-Radosavljevic M
Wien Klin Wochenschr; 2012 Jun; 124(11-12):395-402. PubMed ID: 22699260
[TBL] [Abstract][Full Text] [Related]
69. Enhanced diagnosis of advanced fibrosis and cirrhosis in individuals with NAFLD using FibroScan-based Agile scores.
Sanyal AJ; Foucquier J; Younossi ZM; Harrison SA; Newsome PN; Chan WK; Yilmaz Y; De Ledinghen V; Costentin C; Zheng MH; Wai-Sun Wong V; Elkhashab M; Huss RS; Myers RP; Roux M; Labourdette A; Destro M; Fournier-Poizat C; Miette V; Sandrin L; Boursier J
J Hepatol; 2023 Feb; 78(2):247-259. PubMed ID: 36375686
[TBL] [Abstract][Full Text] [Related]
70. AGILE 3+ Score for the Diagnosis of Advanced Fibrosis and for Predicting Liver-related Events in NAFLD.
Pennisi G; Enea M; Pandolfo A; Celsa C; Antonucci M; Ciccioli C; Infantino G; La Mantia C; Parisi S; Tulone A; Di Marco V; Craxì A; Cammà C; Petta S
Clin Gastroenterol Hepatol; 2023 May; 21(5):1293-1302.e5. PubMed ID: 35842119
[TBL] [Abstract][Full Text] [Related]
71. Combination of Transient Elastography and an Enhanced Liver Fibrosis Test to Assess the Degree of Liver Fibrosis in Patients with Chronic Hepatitis B.
Heo JY; Kim BK; Park JY; Kim DY; Ahn SH; Kim HS; Park YN; Han KH; Song K; Kim SU
Gut Liver; 2018 Mar; 12(2):190-200. PubMed ID: 29069887
[TBL] [Abstract][Full Text] [Related]
72. Transient elastography using Fibroscan is the most reliable noninvasive method for the diagnosis of advanced fibrosis and cirrhosis in alcoholic liver disease.
Fernandez M; Trépo E; Degré D; Gustot T; Verset L; Demetter P; Devière J; Adler M; Moreno C
Eur J Gastroenterol Hepatol; 2015 Sep; 27(9):1074-9. PubMed ID: 26011235
[TBL] [Abstract][Full Text] [Related]
73. Use of biochemical parameters for non-invasive screening of oesophageal varices in comparison to elastography-based approach in patients with compensated advanced chronic liver disease.
Pastrovic F; Madir A; Podrug K; Lucijanic M; Bokun T; Zelenika M; Mustapic S; Unic A; Derek L; Grgurevic I
Biochem Med (Zagreb); 2022 Jun; 32(2):020712. PubMed ID: 35799983
[TBL] [Abstract][Full Text] [Related]
74. CHESS-ALARM score to stratify decompensation risk in compensated advanced chronic liver disease patients: An international multicenter study.
Wong YJ; Li J; Liu C; Chen Z; Chan YH; Putera M; Teh KB; Ang TL; Zhao L; Yan Z; Kumar R; Li X; Qi X
J Gastroenterol Hepatol; 2022 Jun; 37(6):1043-1051. PubMed ID: 35253271
[TBL] [Abstract][Full Text] [Related]
75. FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study.
Newsome PN; Sasso M; Deeks JJ; Paredes A; Boursier J; Chan WK; Yilmaz Y; Czernichow S; Zheng MH; Wong VW; Allison M; Tsochatzis E; Anstee QM; Sheridan DA; Eddowes PJ; Guha IN; Cobbold JF; Paradis V; Bedossa P; Miette V; Fournier-Poizat C; Sandrin L; Harrison SA
Lancet Gastroenterol Hepatol; 2020 Apr; 5(4):362-373. PubMed ID: 32027858
[TBL] [Abstract][Full Text] [Related]
76. Liver stiffness measurement as a noninvasive method for the diagnosis of liver cirrhosis in patients with chronic hepatitis D virus infection.
Sandmann L; Degasperi E; Port K; Aleman S; Wallin JJ; Manuilov D; Da BL; Cornberg M; Lampertico P; Maasoumy B; Wedemeyer H; Deterding K
Aliment Pharmacol Ther; 2024 Mar; 59(6):752-761. PubMed ID: 38212890
[TBL] [Abstract][Full Text] [Related]
77. Liver stiffness in the hepatitis B virus carrier: a non-invasive marker of liver disease influenced by the pattern of transaminases.
Oliveri F; Coco B; Ciccorossi P; Colombatto P; Romagnoli V; Cherubini B; Bonino F; Brunetto MR
World J Gastroenterol; 2008 Oct; 14(40):6154-62. PubMed ID: 18985805
[TBL] [Abstract][Full Text] [Related]
78. Inflammation-adapted liver stiffness values for improved fibrosis staging in patients with hepatitis C virus and alcoholic liver disease.
Mueller S; Englert S; Seitz HK; Badea RI; Erhardt A; Bozaari B; Beaugrand M; Lupșor-Platon M
Liver Int; 2015 Dec; 35(12):2514-21. PubMed ID: 26121926
[TBL] [Abstract][Full Text] [Related]
79. Novel 3D Magnetic Resonance Elastography for the Noninvasive Diagnosis of Advanced Fibrosis in NAFLD: A Prospective Study.
Loomba R; Cui J; Wolfson T; Haufe W; Hooker J; Szeverenyi N; Ang B; Bhatt A; Wang K; Aryafar H; Behling C; Valasek MA; Lin GY; Gamst A; Brenner DA; Yin M; Glaser KJ; Ehman RL; Sirlin CB
Am J Gastroenterol; 2016 Jul; 111(7):986-94. PubMed ID: 27002798
[TBL] [Abstract][Full Text] [Related]
80. Application of Supersonic Shear Imaging to the Baveno VI Criteria and a Combination Model with Spleen Stiffness Measurement to Rule Out High-Risk Varices in Compensated Advanced Chronic Liver Disease.
Cho YS; Kim Y; Sohn JH
Ultraschall Med; 2022 Jun; 43(3):e13-e23. PubMed ID: 32434256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
